As a second example, the structurally complex region containing SMN1 and SMN2 gene copies is associated with spinal muscular atrophy, and successful ASO-mediated gene therapies involve SMN2 (refs. 53,54). This evidence concerns the gene SMN2 and spinal muscular atrophy.